These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 5637163)

  • 21. ENZYME INHIBITORS. I. INHIBITION OF ADENOSINE DEAMINASE BY ISOSTERIC NUCLEOSIDES.
    SCHAEFFER HJ; MARATHE S; ALKS V
    J Pharm Sci; 1964 Nov; 53():1368-70. PubMed ID: 14253597
    [No Abstract]   [Full Text] [Related]  

  • 22. On the rate-determining step in the action of adenosine deaminase.
    Wolfenden R
    Biochemistry; 1969 Jun; 8(6):2409-12. PubMed ID: 5816377
    [No Abstract]   [Full Text] [Related]  

  • 23. Enzyme inhibitors. 8. Studies on the mode of binding of some 6-substituted 9-(hydroxyalkyl)purines to adenosine deaminase.
    Schaeffer HJ; Gvogel D; Vince R
    J Med Chem; 1965 Jul; 8(4):502-6. PubMed ID: 5883714
    [No Abstract]   [Full Text] [Related]  

  • 24. Inhibitors of adenosine deaminase. Studies in combining high-affinity enzyme-binding structural units. erythro-1,6-Dihydro-6-(hydroxymethyl)-9-(2-hydroxy-3-nonyl)purine and erythro-9-(2-hydroxy-3-nonyl)purine.
    Woo PW; Baker DC
    J Med Chem; 1982 May; 25(5):603-5. PubMed ID: 7086847
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enzymatic displacement of oxygen and sulfur from purines.
    Wolfenden RV; Kirsch JF
    J Am Chem Soc; 1968 Nov; 90(24):6849-50. PubMed ID: 5687711
    [No Abstract]   [Full Text] [Related]  

  • 26. Purine nucleosides. XIX. The synthesis of certain 8-chloropurine nucleosides and related derivatives.
    Gerster JF; Hinshaw BC; Robins RK; Townsend LB
    J Org Chem; 1968 Mar; 33(3):1070-3. PubMed ID: 5639343
    [No Abstract]   [Full Text] [Related]  

  • 27. Enzyme inhibitors. XXII. Identity of inhibitor binding site on adenosine deaminase.
    Schaeffer HJ; Schwender CF
    J Pharm Sci; 1968 Jun; 57(6):1070-2. PubMed ID: 5671335
    [No Abstract]   [Full Text] [Related]  

  • 28. Purine nucleosides. XXVII. The synthesis of 1- and 7-methyl-8-oxoguanosine and related nucleosides. The use of the N-amino group as a selective blocking agent in nucleoside synthesis.
    Rizkalla BH; Robins RK; Broom AD
    Biochim Biophys Acta; 1969 Dec; 195(2):285-93. PubMed ID: 5366921
    [No Abstract]   [Full Text] [Related]  

  • 29. Nucleic acids. IV. The catalytic reduction of pyrimidine nucleosides (human liver deaminase inhibitors).
    Hanze AR
    J Am Chem Soc; 1967 Dec; 89(25):6720-5. PubMed ID: 6063658
    [No Abstract]   [Full Text] [Related]  

  • 30. Aminoacyl nucleosides. IV. The rearrangement of N6-(alpha-aminoacyl)adenines to N-(6-purinyl)amino acids. Application to adenosine analogs.
    Chheda GB; Hall RH
    J Org Chem; 1969 Nov; 34(11):3492-8. PubMed ID: 5348134
    [No Abstract]   [Full Text] [Related]  

  • 31. Facile synthesis of 9-substituted 9-deazapurines as potential purine nucleoside phosphorylase inhibitors.
    Shih H; Cottam HB; Carson DA
    Chem Pharm Bull (Tokyo); 2002 Mar; 50(3):364-7. PubMed ID: 11911199
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Irreversible enzyme inhibitors. 73. Active-site-directed irreversible inhibitors of cytosine nucleoside deaminase derived from 1-phenoxypropyl-5-arylcytosines.
    Baker BR; Kelley JL
    J Med Chem; 1969 Nov; 12(6):1046-9. PubMed ID: 5351446
    [No Abstract]   [Full Text] [Related]  

  • 33. Irreversible enzyme inhibitors. CII. On the mode of phenyl binding of 9-phenylguanine to guanine deaminase and xanthine oxidase.
    Baker BR; Wood WF
    J Med Chem; 1967 Nov; 10(6):1101-5. PubMed ID: 6056037
    [No Abstract]   [Full Text] [Related]  

  • 34. Irreversible enzyme inhibitors. 103. 9-(p-Bromoacetamidophenyl)guanine, an irreversible inhibitor of xanthine oxidase.
    Baker BR; Wood WF
    J Med Chem; 1967 Nov; 10(6):1106-9. PubMed ID: 6056038
    [No Abstract]   [Full Text] [Related]  

  • 35. Irreversible enzyme inhibitors. CXXX. Cytosine nucleoside deaminase. I. Hydrophobic bonding with monosubstituted uracils.
    Baker BR; Kelley JL
    J Med Chem; 1968 Jul; 11(4):682-6. PubMed ID: 4876443
    [No Abstract]   [Full Text] [Related]  

  • 36. Irreversible enzyme inhibitors. CXXXI. Cytosine nucleoside deaminase. II. Hydrophobic bonding with disubstituted uracils and cytosines.
    Baker BR; Kelley JL
    J Med Chem; 1968 Jul; 11(4):686-90. PubMed ID: 4876444
    [No Abstract]   [Full Text] [Related]  

  • 37. The synthesis and some biological properties of N-(6-purinyl)peptides.
    Schäfer K; Büllesbach EE; Jollès P; Zahn H
    Biol Chem Hoppe Seyler; 1986 Aug; 367(8):757-68. PubMed ID: 3768142
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and biological evaluation of carbocyclic analogues of lyxofuranosides of 2-amino-6-substituted-purines and 2-amino-6-substituted-8-azapurines.
    Peterson ML; Vince R
    J Med Chem; 1990 Apr; 33(4):1214-9. PubMed ID: 2157013
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis of naturally occurring 6-ureidopurines and their nucleosides.
    Chheda G; Hong CI
    J Med Chem; 1971 Aug; 14(8):748-53. PubMed ID: 5286530
    [No Abstract]   [Full Text] [Related]  

  • 40. Synthesis and biological activity of analogs of naturally occurring 6-ureidopurines and their nucleosides.
    Hong CI; Chheda GB; Dutta SP; O'Grady-Curtis A; Tritsch GL
    J Med Chem; 1973 Feb; 16(2):139-47. PubMed ID: 4734203
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.